Adjuvant therapy for resectable breast cancer Journal Article


Authors: Munster, P. N.; Hudis, C. A.
Article Title: Adjuvant therapy for resectable breast cancer
Abstract: The breast cancer mortality rate is falling, most likely because of a combination of early detection, refined surgical and radiation therapy techniques, and improved systemic therapy efficacy. The proper integration and application of these treatment modalities present evolving challenges for clinicians. Systemic therapy, in particular, is changing rapidly with the advent of new chemotherapy drugs, new classes of agents, and new therapeutic regimens. The most recent studies suggest that optimal outcomes are possible through the broad but appropriate use of hormone therapy and chemotherapy to prevent relapse and possibly prevent second primary tumors. The choice of therapy for patients remains a matter for careful consideration and discussion in each individual case.
Keywords: treatment outcome; cancer surgery; busulfan; review; cisplatin; doxorubicin; fluorouracil; cancer combination chemotherapy; drug efficacy; drug potentiation; paclitaxel; cancer adjuvant therapy; methotrexate; antineoplastic agent; gene overexpression; carboplatin; breast cancer; etoposide; antineoplastic combined chemotherapy protocols; recurrence; cyclophosphamide; breast neoplasms; carmustine; thiotepa; risk assessment; docetaxel; monoclonal antibody; goserelin; doctor patient relation; randomized controlled trials; folinic acid; mitoxantrone; neoplasm metastasis; remission induction; tamoxifen; epirubicin; octreotide; hormonal therapy; taxane derivative; granulocyte colony stimulating factor; oncogene neu; fenretinide; humans; female; priority journal
Journal Title: Hematology/Oncology Clinics of North America
Volume: 13
Issue: 2
ISSN: 0889-8588
Publisher: Elsevier Inc.  
Date Published: 1999-04-01
Start Page: 391
End Page: 413
Language: English
DOI: 10.1016/s0889-8588(05)70062-9
PUBMED: 10363137
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 16 August 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Clifford Hudis
    905 Hudis
  2. Pamela Munster
    30 Munster